基于NCCT深度学习系统与ARCHES评分预测脑出血血肿扩大
本研究开发并验证基于平扫CT的深度学习系统(DLS)预测脑出血血肿扩大,并联合临床变量构建ARCHES评分。数据集包括多中心回顾性2350例、多中心前瞻性460例及单中心前瞻性96例脑出血患者。DLS及ARCHES评分在预测血肿扩大方面优于既往模型。
要点
- 基于平扫CT的DLS模型可自动化、快速评估脑出血血肿扩大风险。
- ARCHES评分联合DLS、基线NIHSS、发病至NCCT时间及规律降压史,判别能力优于BAT评分。
- 适用于急诊场景,可支持强化监测和抗血肿扩大治疗的及时决策。
核心结论
- DLS模型仅基于NCCT提供自动化、客观、快速且易于部署的血肿扩大预测工具。
- DLS模型与ARCHES评分较既往血肿扩大预测模型显著改善风险分层。
研究设计与样本
- 多中心回顾性数据集R纳入2350例脑出血患者。
- 多中心前瞻性数据集P1纳入460例脑出血患者。
- 单中心前瞻性数据集P2纳入96例脑出血患者。
- DLS模型在R-development中开发,在R-validation和P1中进行验证和测试。
- 利用P1-development的多变量logistic回归探索血肿扩大的临床预测因素。
诊断标准与关键数值
- DLS模型在R-development中AUC为0.781(95% CI:0.761-0.800),在P1中表现相近。
- ARCHES评分在P1-development的AUC为0.820(95% CI:0.775-0.859)。
- ARCHES评分优于blend sign、任何低密度及发病至NCCT时间(BAT)评分和meta分析预测模型。
- ARCHES评分为五分制,包含DLS、基线NIHSS、发病至NCCT时间及规律降压史。
临床应用与阅片要点
- DLS模型使平扫CT即可实现自动化和快速的血肿扩大预测。
- ARCHES评分结合影像与临床变量,简便易用,适合急诊环境。
- 两种模型均可改善风险分层并支持急性脑出血的临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop and validate a deep learning system (DLS) model predicting hematoma expansion (HE) based on non-contrast (NC) CT and a score combining with clinical variables.
MATERIALS AND METHODS: The multicenter retrospective dataset (R), the multicenter prospective dataset (P1), and the single-center prospective dataset (P2) enrolled 2350, 460, and 96 intracerebral hemorrhage (ICH) patients for analysis, respectively. The DLS model was developed, validated, and tested in R-development (R-dev), R-validation (R-val), and P1, respectively. After exploring clinical predictors of HE using multivariable logistic regression on P1-development (P1-dev), a five-point score "ARCHES" (Ai-Reinforced intraCerebral Hemorrhage hematoma Expansion Score) combining clinical predictors with the DLS model was created. We compared the discrimination of the ARCHES, DLS, with other models using the receiver operating characteristic (ROC) and DeLong test.
RESULTS: The areas under the curve (AUC) of the DLS model were 0.781 (95% CI: 0.761-0.800) in R-dev, and showed similar results in P1. The ARCHES score, which includes DLS, baseline National Institutes of Health Stroke Scale (NIHSS), onset-to-NCCT time and regular antihypertension history, showed significantly better discrimination (AUC, 0.820; 95% CI: 0.775-0.859) than the blend sign and any hypodensity and time from onset-to-NCCT (BAT) score and the meta-analysis prediction model in P1-dev, P1-validation (P1-val) and P2.
CONCLUSIONS: The DLS model provides an automated, objective, rapid, and readily deployable tool for HE prediction only based on NCCT. The DLS model and the ARCHES score significantly improve risk stratification with better performance than previous HE prediction models, enabling timely clinical decisions for intensive monitoring and anti-HE therapy.
KEY POINTS: Question Lacking reliable NCCT-based deep learning models (DLS) and a score combining with clinical variables for HE prediction. Findings A NCCT-based DLS model and a score combining with clinical variables were developed and tested, both showing good discrimination and calibration in predicting HE. Clinical relevant The DLS model enables automated and rapid HE prediction, while the easy-to-use score combines imaging and clinical variables, making it ideal for use in emergency settings. Both models improve risk stratification and support clinical decision-making in acute intracranial hemorrhage.
引用
- Li, Wu, Ye, et al. Prediction of intracerebral hemorrhage hematoma expansion: value of a novel deep learning system score. Eur Radiol. 2026. PMID: 41609766. doi:10.1007/s00330-025-12138-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。